CD8A and neoplasm: CD8+ T lymphocytes could be suppressed by tumor-induced neutrophil cells, and inhibition of neutrophils accumulation by lorlatinib attenuates PDAC growth (Coffelt et al., 2015; Nielsen et al., 2021).